Inhalations of the heated helium-oxygen mixture (heliox) as addition to standard therapy of community-acquired pneumonia

A. Krasnovskiy, S. Grigoriev, I. Zolkina, H. Loshkareva, A. Alehin, V. Potapov (Moscow, Russian Federation)

Source: Annual Congress 2013 –Lung infections: a clinical point of view
Session: Lung infections: a clinical point of view
Session type: Thematic Poster Session
Number: 2203
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Krasnovskiy, S. Grigoriev, I. Zolkina, H. Loshkareva, A. Alehin, V. Potapov (Moscow, Russian Federation). Inhalations of the heated helium-oxygen mixture (heliox) as addition to standard therapy of community-acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2203

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Number of exacerbations in COPD patients treated with nasal high flow heated and humidified oxygen
Source: International Congress 2014 – COPD markers
Year: 2014


Continuous positive airway pressure (CPAP) treatment and mortality in community-acquired pneumonia (CAP)
Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation
Year: 2007


Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Aerosol vs. nebulisation: comparison of two methods of salbutamol administration in AECB hypercapnic respiratory failure requiring NIMV
Source: Annual Congress 2005 - Non-invasive ventilation: what's new?
Year: 2005


Lung deposition of two bronchodilators in subjects with (COPD) when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI).
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Effectiveness of nebulizing heliox coupled to bronchodilators and body positioning in severe asthma patients
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009

Heated heliox inhalations in treatment and rehabilitation of patients with with COPD
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009


Spirometry and multiple breath nitrogen washout (MBNW) before and after cold dry air challenge (CACh) in children and adolescents with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015


Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

High-flow nasal cannula heated-humidified (HFNC) oxygen (O2) at 2 litres (lt)/kg/min versus low-flow O2 (up to 2lt/min) in pediatric emergency department (PED) and pediatric ward (PW) in infants with bronchiolitis who need O2 administration: A combined prospective randomized controlled and retrospective study: Preliminary results
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015


Use of heated humidified high flow nasal cannula therapy in a tertiary children’s hospital
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016


Surfactant-enforced treatment of pseudomonas-induced pneumonia
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013


Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


Study of adherence to the use of inhaled sodium colistimethate through the I-neb® nebulization system
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Fiberoptic bronchoscopy (FB) during noninvasive ventilation (NIV) in COPD with hypercapnic encephalopathy (he) and bronchial hypersecretion due to community-acquired pneumonia (CAP): a case-control study
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009



Children rhinosinusitis nebulizer inhalation therapy
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009


Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Baseline profiles of subjects randomised in RESPIRE 2 trial of ciprofloxacin dry powder for inhalation (DPI) in non-CF bronchiectasis (NCFB) by pathogen and prior exacerbation rate
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016

COPD and pneumonia
Source: International Congress 2015 – Different data in COPD
Year: 2015